What is ProSciento?
ProSciento, Inc., formerly known as Profil Institute for Clinical Research, Inc., operates as a clinical research organization with a specialized focus on diabetes, obesity, and non-alcoholic steatohepatitis (NASH). The company provides a comprehensive suite of services, including clinical development, regulatory affairs, scientific consultation, data management, statistical analysis, monitoring, quality assurance, and patient recruitment. Its deep expertise in these therapeutic areas positions it as a key player in advancing medical understanding and treatment options for metabolic and liver diseases.
How much funding has ProSciento raised?
ProSciento has raised a total of $2M across 1 funding round:
Debt
$2M
Debt (2020): $2M with participation from PPP
What's next for ProSciento?
The substantial enterprise-level backing indicates ProSciento is poised for significant expansion, likely focusing on scaling its operational capacity, enhancing its service offerings, and potentially broadening its research into adjacent therapeutic areas. This strategic investment will enable the company to further solidify its market position and accelerate its contributions to clinical advancements in metabolic and liver disease research.
See full ProSciento company page
